Arjun Oberoi - Vall d’Hebron Institute of Oncology

基本信息

Career Trajectory

Bio

Interested in experimental immunotherapy, molecular testing for matched therapy and biomarker development.

Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

223P Tumor Whole Genome Sequencing-Based Ultrasensitive Ctdna Analysis As an Early Biomarker for Clinical Outcome in Immune Checkpoint Inhibitor (ICI) Phase I Clinical Trials (ph1) and a Tool for Beyond Progressive Disease by Irecist

R.D.A. Toledo, A.M. Calahorro García, A.B. Moreno,O. Mirallas,V. Galvao,G. Alonso Casal,M. Vieito, I. Braña,A. Oberoi,M.J. Lostes Bardaji, K.C. Keough, F. Navarro, J. Jimenez, A. Mel Olano,P.G. Nuciforo, C. Abbott, J.L. Pugh, R. Chen, S. Boyle, E. Garralda

Annals of Oncology (2024)

Cited0Views0Bibtex

99P Molecular Correlates and Treatment Outcomes of Patients with Brain Metastasis Included in Early Phase Trials: A Single-Center Retrospective Analysis

G. Pretelli,K.I. Rojas Laimito,G. Alonso Casal,M.J. Lostes Bardaji,Aitana Calvo,Vladimir Galvao,A. Oberoi, B. Ortega Morillo,O. Mirallas,O. Saavedra Santa Gadea,C. Saura Manich,M.E. Elez Fernandez,Carolina Ortiz,Eva Muñoz-Couselo,Irene Braña, Joan Galcerán,Enriqueta Felip, E. Garralda, María Vieito

ESMO open (2024): 102325-102325

Cited0Views0Bibtex

630P Debio 0123 + Carboplatin (CP) for Patients (pts) with Advanced Solid Tumors: Safety, Preliminary Efficacy and Determination of Recommended Phase II Dose (RP2D)

H. Gelderblom,O. Saavedra Santa Gadea,M. Jalving,I. Desar, J.A. Gietema,A. Oberoi,C. Van Herpen, J.R. Kroep, R. Frederiksen Franzen,A. Bellon,S. Micallef,T. Tat, V. Dozio,N. Luong,E. Rodrigo Imedio

Annals of Oncology (2024)

Cited0Views0Bibtex

29O Clinical Characterization of Long-Term Survivors in Phase I Clinical Trials

O. Mirallas, A. Rossi, E.M. Fernández, E. Garcia-Galea,K.S. Vega Cano, J. Ginard Moya,A. Hernando Calvo,G. Pretelli,M.J. Lostes Bardaji,A. Oberoi,V. Galvao,K.I. Rojas Laimito, B. Ortega Morillo,G. Alonso Casal,S. Aguilar Izquierdo, I. Braña, R. Dienstmann,M. Vieito Villar, E. Garralda

ESMO Open (2024)

Cited0Views0Bibtex

93P Evolving Landscape of Targeted Therapies (TT) in Early Phase Clinical Trials (EPCT): the RESISTANCE Project (360R)

Anthony Rossi,Irene Braña,María Vieito,G. Alonso Casal,O. Saavedra Santa Gadea,Oriol Mirallas,M.J. Lostes Bardaji,Vladimir Galvao,K.I. Rojas Laimito,A. Oberoi,G. Pretelli, B. Ortega Morillo, M. Taberna Sanz,S. Aguilar Izquierdo,Kira Raskina,Rodrigo Dienstmann,Ana Vivancos,Josep Tabernero,Elena Garralda,Aitana Calvo

ESMO open (2024): 102319-102319

Cited0Views0Bibtex

Prognostic and Predictive Value of Ultrasensitive Ctdna Monitoring in a Metastatic Pan-Cancer Cohort Treated with Immune Checkpoint Inhibitors in the Context of Phase 1 Clinical Trials

Rodrigo De Almeida Toledo, Alma M. Calahorro Garcia,Oriol Mirallas,Ana Moreno,Vladimir Galvao,Guzman Alonso, Maria Vieito,Irene Brana,Arjun Oberoi, M. Julia Lostes-Bardaji,Jose Jimenez, Marta Sanz,Cristina Viaplana, Raquel Perez-Lopez,Paolo Nuciforo,Charles Abbott,Jason Pugh,Richard Chen, Sean Michael Boyle,Elena Garralda

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

664P Impact of Treatment Beyond Progression (TBP) in Patients Treated with Immunotherapy (IO) in Phase I Trials (Ph1)

M.J. Lostes Bardaji, A. Mel Olano,O. Mirallas,D. Morchón Araujo, S. Pérez Fernandez,K. Raskina,V. Galvao,G. Alonso Casal,A. Oberoi,G. Pretelli,K.I. Rojas Laimito, B. Ortega Morillo,C. Ortiz Velez,E. Muñoz-Couselo,C. Viaplana,M. Vieito, I. Braña, R. Dienstmann,A. Hernando Calvo, E. Garralda

Annals of Oncology (2024)

Cited0Views0Bibtex

1018P Leveraging Innate and Adaptive Immunity with AFM24 and Atezolizumab in Metastatic Gastric Cancer

O. Saavedra Santa Gadea,A. Oberoi,J.S. Lopez, A. Cervantes,M. Ponz-Sarvise, H.R. Kim,A.B. El-Khoueiry,B. Shim, J.W. Kim, V. Boni,I. Lugowska, C. Szczylik, W. Rogowski,S. Mandziuk, R. Ramlau, U. Gaertner, S. Lutkewitz, D. Schütz,M. Emig,D. Morales-Espinosa

Annals of Oncology (2024)

Cited0Views0Bibtex

538P Single-center Retrospective Analysis of Patients with Brain Metastases Included in Early Phase Clinical Trials

G. Pretelli,K. I. Rojas Laimito,G. Alonso,M. J. Lostes Bardaji,A. Hernando Calvo,V. Galvao,A. Oberoi, B. Ortega Morillo,O. Saavedra Santa Gadea, J. Ginard Moya,C. Saura Manich,M. E. Elez Fernandez, C. Ortiz,E. Munoz Couselo,I. Brana,A. Callejo Perez,J. Carles Galceran,E. Felip,E. Garralda,M. Vieito Villar

Annals of oncology (2023): S405-S406

Cited0Views0Bibtex

1023MO Decoding Immunotherapy Resistance: A Novel Multiparametric Magnetic Resonance Imaging Approach to Stratify Cancer Patient Outcomes

K. Bernatowicz,F. Grussu, C. Tozzi, A. Voronova,M. Sanz,M. Vieito Villar,G. Alonso Casal,V. Galvao,A. Oberoi,I. Brana,O. Saavedra Santa Gadea,E. Munoz Couselo,G. Serna, A. B. Moreno, M. Rotxes,J. Tabernero,R. D. A. Toledo,P. G. Nuciforo,E. Garralda,R. Perez Lopez

Annals of oncology (2023): S622-S623

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn